Azitra Inc (AZTR)

Currency in USD
0.1679
-0.0120(-6.67%)
Closed·
Pre Market
0.1734+0.0055(+3.28%)
·
AZTR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 10 days
AZTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.16420.1855
52 wk Range
0.16110.9780
Key Statistics
Prev. Close
0.1679
Open
0.18
Day's Range
0.1642-0.1855
52 wk Range
0.1611-0.978
Volume
1.1M
Average Volume (3m)
2.05M
1-Year Change
-68.91%
Book Value / Share
0.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.5000
Upside
+1,388.98%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Azitra Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Azitra Inc Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.

Compare AZTR to Peers and Sector

Metrics to compare
AZTR
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.5x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
0.7x1.7x2.6x
Price / LTM Sales
385.6x9.7x3.3x
Upside (Analyst Target)
-314.9%43.4%
Fair Value Upside
Unlock31.7%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.5000
(+1,388.98% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.23 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AZTR Income Statement

People Also Watch

115.49
TFX
+3.05%
1.0000
GNS
-12.28%
0.2311
PCSA
+1.58%
0.387
ADIL
-6.30%
0.94
KLTO
-1.05%

FAQ

What Stock Exchange Does Azitra Trade On?

Azitra is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Azitra?

The stock symbol for Azitra is "AZTR."

What Is the Azitra Market Cap?

As of today, Azitra market cap is 2.89M.

What Is Azitra's Earnings Per Share (TTM)?

The Azitra EPS (TTM) is -1.32.

When Is the Next Azitra Earnings Date?

Azitra will release its next earnings report on 17 Aug 2025.

From a Technical Analysis Perspective, Is AZTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Azitra Stock Split?

Azitra has split 1 times.

How Many Employees Does Azitra Have?

Azitra has 12 employees.

What is the current trading status of Azitra (AZTR)?

As of 08 Aug 2025, Azitra (AZTR) is trading at a price of 0.17, with a previous close of 0.17. The stock has fluctuated within a day range of 0.16 to 0.19, while its 52-week range spans from 0.16 to 0.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.